Image-Guided Cancer Nanomedicine
AbstractMultifunctional nanoparticles with superior imaging properties and therapeutic effects have been extensively developed for the nanomedicine. However, tumor-intrinsic barriers and tumor heterogeneity have resulted in low in vivo therapeutic efficacy. The poor in vivo targeting efficiency in passive and active targeting of nano-therapeutics along with the toxicity of nanoparticles has been a major problem in nanomedicine. Recently, image-guided nanomedicine, which can deliver nanoparticles locally using non-invasive imaging and interventional oncology techniques, has been paid attention as a new opportunity of nanomedicine. This short review will discuss the existing challenges in nanomedicine and describe the prospects for future image-guided nanomedicine. View Full-Text
Share & Cite This Article
Kim, D.-H. Image-Guided Cancer Nanomedicine. J. Imaging 2018, 4, 18.
Kim D-H. Image-Guided Cancer Nanomedicine. Journal of Imaging. 2018; 4(1):18.Chicago/Turabian Style
Kim, Dong-Hyun. 2018. "Image-Guided Cancer Nanomedicine." J. Imaging 4, no. 1: 18.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.